Penwest inks TIMERx formulation deal with Otsuka
Penwest Pharmaceuticals is developing a formulation of an undisclosed Otsuka Pharmaceutical compound using its TIMERx drug delivery technology.
Penwest Pharmaceuticals is developing a formulation of an undisclosed Otsuka Pharmaceutical compound using its TIMERx drug delivery technology.
Detection of Mycoplasma contamination in biologics manufacture can be cut from up to 35 days to four hours using Millipore’s MilliPROBE, according to the company.
OmniComm has connected its TrialMaster EDC system to Microsoft (MS) HealthVault, allowing health records and data to be transferred to a patient’s file during clinical trials.
Nipro Medical has recalled all batches of its GlucoPro insulin syringes in the US after discovering that the needles could detach during use.
Parexel says while restructuring charges hit fiscal Q2 profits, gains made by its late-stage trials business are an indication of recovering demand.
The Formulation Innovation Network has been set up in the North of England as a means of enhancing innovation for all formulation-orientated businesses.
LTS Lohmann Therapie-Systeme (LTS) signs up as manufacturer of drugs that use IntelGenx’s VersaFilm delivery technology.
The SPMC of Sri Lanka is seeking a $10m (€7.1m) loan to buy high-speed tablet and capsule filling machines and ensure it can meet the island’s demand for safe medicines.